Invention Grant
- Patent Title: CD27L antigen binding proteins
-
Application No.: US15402478Application Date: 2017-01-10
-
Publication No.: US10266604B2Publication Date: 2019-04-23
- Inventor: John M. Delaney , William Christian Fanslow, III , Chadwick Terence King
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61K47/68 ; C07K16/28 ; A61K31/5365 ; A61K39/395 ; A61K39/00
Abstract:
The present invention relates to CD27L antigen binding proteins, such an antibodies, polynucleotides encoding said CD27l antigen binding proteins, antibody drug conjugate compositions, and methods for diagnosing and treating diseases associated with CD27L expression.
Public/Granted literature
- US20170267775A1 CD27L Antigen Binding Proteins Public/Granted day:2017-09-21
Information query
